Harbour Investments »

Pliant Therapeutics shares owned by Harbour Investments

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Harbour Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $614 488 1.26
2023-12-31 $453 25 18.12
2023-09-30 $434 25 17.36
2021-09-30 $6.0k 381 15.75
2021-06-30 $10k 350 28.57
2021-03-31 $14k 348 40.23

More positions owned by Harbour Investments

Vanguard S&p 500 Etf Etf (VOO)
Invesco Qqq Trust Series I Etf (QQQ)
First Trust Smid Cap Rising Dividend Achievers Etf Etf (SDVY)
Apple Stock (AAPL)
First Trust Smith Unconstrained Bond Etf Etf (UCON)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ft Vest Laddered Buffer Etf Etf (BUFR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Core S&p 500 Etf Etf (IVV)
Capital Group Core Plus Income Etf Etf (CGCP)
State Street Spdr S&p 500 Etf Etf (SPY)
First Trust Rising Dividend Achievers Etf Etf (RDVY)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares S&p 500 Value Etf Etf (IVE)
Schwab Us Dividend Equity Etf Etf (SCHD)

View all positions for Harbour Investments

Top funds holding Pliant Therapeutics

Tang Capital Management
Citadel Advisors
Blue Owl Capital Holdings
Vanguard Group
ADAR1 Capital Management
Acadian Asset Management
Vanguard Capital Management
Two Sigma Investments
Monaco Asset Management SAM
Woodline Partners
Prosight Management
BML Capital Management
Peapod Lane Capital
Millennium Management
BlackRock

View all funds holding Pliant Therapeutics